Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.06    0.005 (0.47%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

Changes to the Board

22 May 2025 15:57

RNS Number : 8438J
CVC Income & Growth Limited
22 May 2025
 

22 May 2025

 

CVC Income & Growth Limited

(the Company or CVC)

 

Changes to the Board

 

 

The Board of the Company announces that it has agreed with Ms Stephanie Carbonneil, Senior Independent Director and Chair of the Nomination and Remuneration Committee, that she will step down from the Board due to her increasing time commitment required of her executive role.

 

To allow for an orderly handover, Ms Carbonneil will step down from the Board with effect from 21 August 2025.

 

The Company is pleased to announce that Ms Esther Gilbert has been appointed Senior Independent Director and Ms Vanessa Neill has been appointed as Chair of the Nomination and Remuneration Committee, both effective 21 August 2025.

 

Ms Neill and Ms Gilbert have served on the Board since January 2022 and September 2022 respectively.

 

The Board would like to express its sincere thanks to Ms Carbonneil for her contribution to the Board, as Senior Independent Director, and as Chair of the Nomination and Remuneration Committee over the years.

 

Robert Kirkby, Chair of the Board commented: "I would like to thank Stephanie, on behalf of the Board, for her tremendous contribution to CVC, as well as the insights and experience she has brought to her role as Chair of the Nomination and Remuneration Committee. Stephanie has been with CVC since February 2019 and with her extensive knowledge of the investment trust market has been a valuable Board member as we have advanced the Company on its trajectory of profitable growth. I wish her well in her future endeavours.

Welcoming both Esther and Vanessa to their respective leadership roles, CVC retains a strong non-executive leadership team with significant years of industry knowledge and expertise, ensuring the Company remains well positioned for growth."

 

This announcement is released in compliance with UK Listing Rule 6.4.6.

 

END

 

Enquiries:

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALSAASSSEFA
Date   Source Headline
30th Apr 20257:00 amRNSDividend Declaration
29th Apr 20254:50 pmRNSResult of AGM
28th Apr 20254:03 pmRNSIssue of Equity
25th Apr 20259:35 amRNSNet Asset Value Weekly to 17 Apr 2025
24th Apr 20255:49 pmRNSIssue of Equity
23rd Apr 20253:27 pmRNSMONTHLY REPORT
23rd Apr 202511:50 amRNSNet Asset Value Weekly to 11 Apr 2025
22nd Apr 202511:37 amRNSMarch 2025 Tender Price
11th Apr 20254:49 pmRNSNotice of 2025 Annual General Meeting
10th Apr 20254:05 pmRNSNet Asset Value Weekly to 04 Apr 2025
7th Apr 20253:53 pmRNSDirector/PDMR Shareholding
7th Apr 202511:42 amRNSDirector/PDMR Shareholding
2nd Apr 20256:10 pmRNSNet Asset Value Weekly to 28 Mar 2025
1st Apr 202511:34 amRNSTotal Voting Rights
27th Mar 20253:12 pmRNSIssue of Equity
27th Mar 20252:45 pmRNSNet Asset Value Weekly to 21 Mar 2025
27th Mar 20257:00 amRNS2024 Annual Report and Financial Statements
25th Mar 20254:06 pmRNSIssue of Equity
20th Mar 20253:30 pmRNSNet Asset Value Weekly to 14 Mar 2025
19th Mar 202511:17 amRNSMONTHLY REPORT
19th Mar 202511:07 amRNSIssue of Equity
14th Mar 202510:16 amRNSNet Asset Value Month End 28 Feb 2025
13th Mar 20251:50 pmRNSNet Asset Value Weekly to 07 Mar 2025
12th Mar 20253:13 pmRNSIssue of Equity
10th Mar 202512:11 pmRNSIssue of Equity
6th Mar 20254:35 pmRNSNet Asset Value Weekly to 28 Feb 2025
6th Mar 202510:43 amRNSRESULTS OF PLACINGS FOR MARCH 2025 TENDER
3rd Mar 20254:55 pmRNSTotal Voting Rights
3rd Mar 20254:06 pmRNSIssue of Equity
27th Feb 202512:35 pmRNSNet Asset Value Weekly to 21 Feb 2025
27th Feb 202510:55 amRNSIssue of Equity
26th Feb 20253:36 pmRNSIssue of Equity
26th Feb 20259:37 amRNSMONTHLY REPORT
21st Feb 20255:09 pmRNSNet Asset Value Weekly to 14 Feb 2025
18th Feb 20259:01 amRNSNet Asset Value Month End 31 Jan 2025
14th Feb 20255:27 pmRNSResult of March 25 Tender Process (Replacement)
14th Feb 20252:38 pmRNSResult of March 2025 Semi-Annual Tender Process
14th Feb 20251:50 pmRNSNet Asset Value Weekly to 07 Feb 2025
14th Feb 202510:29 amRNSIssue of Equity
13th Feb 20254:58 pmRNSIssue of Equity
11th Feb 202511:54 amRNSDirector/PDMR Shareholding
11th Feb 20259:47 amRNSHolding(s) in Company
6th Feb 20255:10 pmRNSNet Asset Value Weekly to 31 Jan 2025
6th Feb 20251:32 pmRNSIssue of Equity
5th Feb 20254:36 pmRNSIssue of Equity
5th Feb 20253:58 pmRNSDirector/PDMR Shareholding
4th Feb 20253:10 pmRNSHolding(s) in Company
4th Feb 202510:01 amRNSHolding(s) in Company
3rd Feb 20254:58 pmRNSTotal Voting Rights
31st Jan 202510:11 amRNSNet Asset Value Weekly to 24 Jan 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.